AMDF logo

The AMDF is a 501(c)(3) non-profit, publicly supported organization. Contributions are tax deductible to the extent allowed by law.



Juvenile Onset Macular Degeneration, Stargardt Disease,
Fundus Flavimaculatus, Stargardt Macular Dystrophy


I. Autosomal Recessive Stargardt Macular Dystrophy
(90-95% of all cases)

Definition: Early onset macular dystrophy, leading to macular degeneration and blindness.

Clinical Presentation: Early unexplained visual loss associated with retinal changes, abnormalities of the retinal epithelium, later atrophic macular degeneration with or w/out yellow fundus flecks, pallor of optic nerve head and minimal color vision defects.

Cause: Defective ABCA4.
Diagnosis: Based on clinical presentation, electrooculography, electroretinography, DNA sequence variations and inheritance patterns.
Treatments: No treatment for Stargardt’ exists. One option may be laser treatment for sealing leaking vessels as used for wet macular degeneration to coagulate choroidal neovascularization membranes.
Visual aids may help.

Prognosis: Autosomal recessive means that there is a 25% chance that a child will inherit the diseased gene from each parent.

What to do:
Minimize exposure to bright light, obtain genetic counseling.

II. Autosomal Dominant Stargardt-Like Macular Dystrophy
(5-10% cases)

Definition: Early onset macular dystrophy, leading to macular degeneration and blindness.

Clinical Presentation: Early onset visual loss at age 10-20 associated with retinal changes and abnormalities of the retinal epithelium with blurry, uncorrectable vision and difficulty adapting to bright light.
Subsequent changes include atrophic macular degeneration with or w/out yellow fundus flecks, pallor of optic nerve head and minimal color vision defects. Highly penetrant by age 20; almost completely penetrant by age 30.

Cause: Defective ELOVL4 gene.

Diagnosis: Based on clinical presentation, electrooculography, electroretinography DNA sequence variations and inheritance patterns.

Treatments: No treatment for Stargardt exists. Visual aids may help.

Prognosis: Autosomal dominant means that there is a 50% chance that children will inherit the diseased gene; 90% of patients over 20 years are affected with vision of 20/200 and legal blindness by late 20s. By 40-50 the vision is 20/400 and by age 60-70 it is 20/800. Non-macular visual function however is retained throughout life.

What to do: Minimize exposure to bright light, obtain genetic counseling.

Back to Stargardt Disease

American Macular
Degeneration Foundation
PO Box 515
Northampton MA 01061-0515
1.888.MACULAR
1.888.622.8527
Email
Privacy Policy

All contents ©Copyright 1998-2012 AMDF. All Rights Reserved.